TCR upstart gets fresh funding as it looks to charge toward the clinic

While several companies have been finding success in the TCR-T cell therapy space — with Intellia having its treatment accepted by the FDA last year — another company is using machine learning to get in on the action and find a candidate to bring toward the clinic.

ImmunoScape, a...

Click to view original post